4 newer rulings cite the same tariff codes.

Classification can shift over time. Review the more recent rulings below before relying on this one.

N314364 N3 Ruling Active

The tariff classification of Aripiprazole Lauroxil (CAS No. 1259305-29-7) in bulk form, from Spain. Correction to Ruling Number N289285

Issued September 17, 2020 by U.S. Customs and Border Protection.

Cite this ruling

Copies to clipboard

N3 N314364 (September 17, 2020)

Tariff classification

HTS codes: 2933.79.0800

Headings: 2933

Product description

Aripiprazole Lauroxil is an atypical antipsychotic indicated for the treatment of schizophrenia.

CBP rationale

the applicable subheading. A complete corrected ruling follows. In your letter dated August 15, 2017, you requested a tariff classification ruling. Aripiprazole Lauroxil is an atypical antipsychotic indicated for the treatment of schizophrenia. The applicable subheading for the Aripiprazole Lauroxil in bulk form will be 2933.79.0800, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Heterocyclic compounds with nitrogen hetero-atom(s) only: Lactams: Other lactams: Aromatic or modified aromatic: Other: Products described in additional U.

Full text

N314364 September 17, 2020 CLA-2-29:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 2933.79.0800 Ms. Sheila Heerdt Ren Pharm International Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Aripiprazole Lauroxil (CAS No. 1259305-29-7) in bulk form, from Spain. Correction to Ruling Number N289285 Dear Heerdt: This replaces Ruling Number N289285, dated September 13, 2017, which contained a typographical error where the last few digits were reversed in the applicable subheading. A complete corrected ruling follows. In your letter dated August 15, 2017, you requested a tariff classification ruling. Aripiprazole Lauroxil is an atypical antipsychotic indicated for the treatment of schizophrenia. The applicable subheading for the Aripiprazole Lauroxil in bulk form will be 2933.79.0800, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Heterocyclic compounds with nitrogen hetero-atom(s) only: Lactams: Other lactams: Aromatic or modified aromatic: Other: Products described in additional U.S. note 3 to section VI." The general rate of duty will be 6.5 percent ad valorem. Currently, Aripiprazole Lauroxil is not listed in the Pharmaceutical Appendix to the Tariff Schedule. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division

View original on CBP CROSS →

Ruling history

More rulings on the same tariff codes

Follow N314364

Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.

One email per day at most. Confirm your address once, unsubscribe anytime.

Searching CBP rulings the smart way

Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.